Application of machine intelligence technology in the detection of vaccines and medicines for SARS-CoV-2

Abstract

Researchers have found many similarities between the 2003 severe acute respiratory syndrome (SARS) virus and SARSCoV-19 through existing data that reveal the SARS’s cause. Artificial intelligence (AI) learning models can be created to predict drug structures that can be used to treat COVID-19. Despite the effectively demonstrated repurposed drugs, more repurposed drugs should be recognized. Furthermore, technological advancements have been helpful in the battle against COVID-19. Machine intelligence technology can support this procedure by rapidly determining adequate and effective drugs against COVID-19 and by overcoming any barrier between a large number of repurposed drugs, laboratory/clinical testing, and final drug authorization. This paper reviews the proposed vaccines and medicines for SARSCoV-2 and the current application of AI in drug repurposing for COVID-19 treatment.